A detailed history of Jump Financial, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Jump Financial, LLC holds 66,189 shares of IRWD stock, worth $144,292. This represents 0.01% of its overall portfolio holdings.

Number of Shares
66,189
Holding current value
$144,292
% of portfolio
0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.93 - $7.04 $260,122 - $465,970
66,189 New
66,189 $272,000
Q4 2023

Oct 21, 2024

BUY
$8.79 - $11.51 $157,991 - $206,880
17,974 Added 112.41%
33,963 $388,000
Q4 2023

Feb 07, 2024

BUY
$8.79 - $11.51 $298,534 - $390,914
33,963 New
33,963 $388,000
Q2 2023

Oct 21, 2024

SELL
$10.1 - $11.6 $789,658 - $906,934
-78,184 Reduced 83.02%
15,989 $170,000
Q2 2023

Aug 07, 2023

SELL
$10.1 - $11.6 $789,658 - $906,934
-78,184 Reduced 83.02%
15,989 $170,000
Q1 2023

Oct 21, 2024

BUY
$10.37 - $12.56 $976,574 - $1.18 Million
94,173 New
94,173 $990,000
Q1 2023

May 03, 2023

SELL
$10.37 - $12.56 $257,082 - $311,374
-24,791 Reduced 20.84%
94,173 $990,000
Q4 2022

Feb 13, 2023

BUY
$9.9 - $12.43 $1.03 Million - $1.3 Million
104,220 Added 706.86%
118,964 $1.47 Million
Q3 2022

Nov 07, 2022

BUY
$10.14 - $12.38 $149,504 - $182,530
14,744 New
14,744 $153,000
Q2 2022

Aug 09, 2022

SELL
$11.05 - $12.72 $1.02 Million - $1.18 Million
-92,587 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$10.61 - $12.88 $982,348 - $1.19 Million
92,587 New
92,587 $1.16 Million
Q4 2021

Feb 10, 2022

SELL
$10.86 - $13.95 $779,748 - $1 Million
-71,800 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$11.92 - $13.92 $1.6 Million - $1.87 Million
-134,500 Reduced 65.2%
71,800 $938,000
Q2 2021

Aug 13, 2021

BUY
$10.16 - $13.11 $1.88 Million - $2.43 Million
185,300 Added 882.38%
206,300 $2.66 Million
Q1 2021

May 17, 2021

BUY
$9.04 - $11.86 $189,839 - $249,060
21,000 New
21,000 $235,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $334M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.